Search - tctmd.com

Displaying 581 - 600 of 2597

Sort: Relevancy | Date

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

Presentation TCT 2021

Newer Invasive Pressure Monitoring Devices

Presenter: Liviu Klein

November 06, 2021

News Conference News TCT 2021

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Caitlin E. Cox

November 06, 2021

Presentation TCT 2021

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Presenter: W. H. Wilson Tang

November 06, 2021

Presentation TCT 2021

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Presenter: Roberto Galea

November 06, 2021

News Conference News TCT 2021

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

Todd Neale

November 06, 2021

Presentation TCT 2021

Overview of Devices for HF: Current and Future Prospects

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

Percutaneous Retrieval of a Malfunctioning WATCHMAN Device

Presenter: Coty Jewell

November 05, 2021

News Conference News TCT 2021

More DAPT Duration Data, More Calls to Tailor to Individual Patients

Shelley Wood

November 05, 2021

Presentation TCT 2021

First Dedicated Transcatheter Leaflet Splitting Device From Bench to FIH (ShortCut)

Presenter: Susheel Kodali

November 05, 2021

Presentation TCT 2021

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Presenter: William C. Altman

November 05, 2021

News Conference News TCT 2021

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

L.A. McKeown

November 05, 2021

Presentation TCT 2021

Special (Device/Drug) Approaches to Infarct Size Reduction

Presenter: Giovanni Luigi De Maria

November 05, 2021

Presentation TCT 2021

Digital Health Apps in Cardiovascular Device Trials, From FDA Perspective

Presenter: George Van Hare

November 05, 2021

Presentation TCT 2021

Digital Health Apps in Cardiovascular Device Trials, a Clinician's Perspective

Presenter: Mintu Turakhia

November 05, 2021

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Todd Neale

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

Presenter: William Abraham

November 05, 2021

Presentation TCT 2021

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

Presenter: Dhanunjaya Lakkireddy

November 05, 2021

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

Advertisement

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Newer Invasive Pressure Monitoring Devices

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

Overview of Devices for HF: Current and Future Prospects

Percutaneous Retrieval of a Malfunctioning WATCHMAN Device

More DAPT Duration Data, More Calls to Tailor to Individual Patients

First Dedicated Transcatheter Leaflet Splitting Device From Bench to FIH (ShortCut)

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

Special (Device/Drug) Approaches to Infarct Size Reduction

Digital Health Apps in Cardiovascular Device Trials, From FDA Perspective

Digital Health Apps in Cardiovascular Device Trials, a Clinician's Perspective

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content